Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 148.00
-2.50 (-1.66%)
Jul 31, 2025, 12:34 PM IDT
TLV:IMED Revenue
In the year 2024, Imed Infinity Medical-Limited Partnership had annual revenue of $41.00K USD, down -104.35%. Imed Infinity Medical-Limited Partnership had revenue of $161.00K in the half year ending December 31, 2024, a decrease of -19.50%.
Revenue
$41.00K
Revenue Growth
-104.35%
P/S Ratio
40.67
Revenue / Employee
$585.71
Employees
70
Market Cap
6.07M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.00K | 983.00K | -104.35% |
| Dec 31, 2023 | -942.00K | -1.14M | -571.00% |
| Dec 31, 2022 | 200.00K | 125.00K | 166.67% |
| Dec 31, 2021 | 75.00K | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 235.09M |
| BrainsWay | 161.81M |
| Novolog (Pharm-Up 1966) | 2.07B |
| Ilex Medical | 922.08M |